相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Folate-decorated nanogels for targeted therapy of ovarian cancer
Natalia V. Nukolova et al.
BIOMATERIALS (2011)
Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery
Yuanpei Li et al.
BIOMATERIALS (2011)
Docetaxel Distribution Following Intraperitoneal Administration in Mice
Payam Zahedi et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2011)
Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer
Raquel De Souza et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Combination Drug Delivery Strategy for the Treatment of Multidrug Resistant Ovarian Cancer
Payam Zahedi et al.
MOLECULAR PHARMACEUTICS (2011)
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
Gooitzen M. van Dam et al.
NATURE MEDICINE (2011)
Nanotechnology-Based Cancer Therapeutics-Promise and Challenge-Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
Dorothy Farrell et al.
PHARMACEUTICAL RESEARCH (2011)
Augmentation of Therapeutic Efficacy in Drug-Resistant Tumor Models Using Ceramide Coadministration in Temporal-Controlled Polymer-Blend Nanoparticle Delivery Systems
Lilian E. van Vlerken et al.
AAPS JOURNAL (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Inhibiting Tumor Growth by Targeting Tumor Vasculature with Galectin-1 Antagonist Anginex Conjugated to the Cytotoxic Acylfulvene, 6-Hydroxylpropylacylfulvene
Ruud P. M. Dings et al.
BIOCONJUGATE CHEMISTRY (2010)
Curcumin polymers as anticancer conjugates
Huadong Tang et al.
BIOMATERIALS (2010)
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
Zhongling Feng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic That Targets Both Murine and Human Ovarian Tumor Endothelial Cells In vivo
Ira Winer et al.
CANCER RESEARCH (2010)
Polymeric drug delivery systems for localized cancer chemotherapy
Raquel De Souza et al.
DRUG DELIVERY (2010)
Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer
Heidi J. Gray et al.
GYNECOLOGIC ONCOLOGY (2010)
Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications
Jamie L. Lesnock et al.
GYNECOLOGIC ONCOLOGY (2010)
Achievements and unmet needs in the management of advanced ovarian cancer
Valentina Guarneri et al.
GYNECOLOGIC ONCOLOGY (2010)
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice
A. Cirstoiu-Hapca et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Endocytosis of nanomedicines
Gaurav Sahay et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer
Raquel De Souza et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence
Wim P. Ceelen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Ovarian cancer: the duplicity of CA125 measurement
Amer K. Karam et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
K. Levanon et al.
ONCOGENE (2010)
Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery
Donghui Zheng et al.
ONCOLOGY REPORTS (2010)
PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation
Saijie Zhu et al.
PHARMACEUTICAL RESEARCH (2010)
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy
Abhimanyu S. Paraskar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The detection, treatment, and biology of epithelial ovarian cancer
Jennifer A. A. Gubbels et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Ovarian Cancer Pathogenesis: A Model in Evolution
Alison M. Karst et al.
JOURNAL OF ONCOLOGY (2010)
OncoGel (ReGel/paclitaxel) - Clinical applications for a novel paclitaxel delivery system
Nancy L. Elstad et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Biocompatibility of injectable chitosan-phospholipid implant systems
Raquel De Souza et al.
BIOMATERIALS (2009)
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer
Kai Xiao et al.
BIOMATERIALS (2009)
An Update on the Use of Intraperitoneal Chemotherapy in the Management of Ovarian Cancer
Maurie Markman
CANCER JOURNAL (2009)
Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP
Xiaowei Dong et al.
CANCER RESEARCH (2009)
Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo
Xiao-yan Zhang et al.
CANCER RESEARCH (2009)
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
Tripta Bansal et al.
DRUG DISCOVERY TODAY (2009)
Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles
Xiang Rong Song et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Role of cytoreductive surgery in recurrent ovarian cancer
Philipp Harter et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer
R. Wendel Naumann et al.
GYNECOLOGIC ONCOLOGY (2009)
Chitosan-phospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity
Payam Zahedi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel
Yang Yang et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
Yogesh Patil et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles
Natalya Y. Rapoport et al.
JOURNAL OF CONTROLLED RELEASE (2009)
RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer
Hui Zhao et al.
JOURNAL OF DRUG TARGETING (2009)
Reversal of Multidrug Resistance by Methoxypolyethylene Glycol-block-Polycaprolactone Diblock Copolymers Through the Inhibition of P-Glycoprotein Function
Praveen Elamanchili et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
Srinivas Ganta et al.
MOLECULAR PHARMACEUTICS (2009)
In Vivo Evaluation of Doxorubicin-Loaded Polymeric Micelles Targeting Folate Receptors and Early Endosomal pH in Drug-Resistant Ovarian Cancer
Dongin Kim et al.
MOLECULAR PHARMACEUTICS (2009)
Screening for Ovarian Cancer
Daniel L. Clarke-Pearson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Polymer-drug conjugates: Recent development in clinical oncology
Chun Li et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience
Frank J. Attenello et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts
Rutger W. H. M. Staffhorst et al.
ANTI-CANCER DRUGS (2008)
Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging
V. Vassileva et al.
BRITISH JOURNAL OF CANCER (2008)
Multi-functional nanocarriers to overcome tumor drug resistance
Lara S. Jabr-Milane et al.
CANCER TREATMENT REVIEWS (2008)
An overview of cancer multidrug resistance: a still unsolved problem
H. Lage
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles
Harikrishna Devalapally et al.
CLINICAL CANCER RESEARCH (2008)
Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
Fabio Pastorino et al.
CLINICAL CANCER RESEARCH (2008)
Pharmaceutical management of ovarian cancer - Current status
Maurie Markman
DRUGS (2008)
Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma
Y. Liu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Influence of molecular organization and interactions on drug release for an injectable polymer-lipid blend
Justin Grant et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Early events in the pathogenesis of epithelial ovarian cancer
Charles N. Landen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Raghavendra C. Mundargi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Tumor-Penetrating Microparticles for Intraperitoneal Therapy of Ovarian Cancer
Ze Lu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma
Dalia Somjen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters
Elena A. Dubikovskaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nanoparticles for drug delivery in cancer treatment
Barbara Haley et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model
Vessela Vassileva et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer
Harikrishna Devalapally et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer:: Intergroup trial of the AGO-Ovar/AIO and EBMT
Volker Moebus et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel
Max Tsai et al.
PHARMACEUTICAL RESEARCH (2007)
Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(β-aminoester)-graft-PEG for cancer chemotherapy
Wei Jin et al.
DRUG DELIVERY (2007)
Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model
Harikrishna Devalapally et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting
Hongxia Lu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Alternative drug formulations of docetaxel: a review
Frederike K. Engels et al.
ANTI-CANCER DRUGS (2007)
Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors
Emmanuel A. Ho et al.
JOURNAL OF CONTROLLED RELEASE (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer
Ho Lun Wong et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Intraperitoneal chemotherapy and the NCI clinical announcement
Edward L. Trimble et al.
GYNECOLOGIC ONCOLOGY (2006)
A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer®) in recurrent ovarian cancer:: A Gynecologic Oncology Group study
Deborah K. Armstrong et al.
GYNECOLOGIC ONCOLOGY (2006)
Ovarian cancer
Nicoletta Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer:: The Finnish Ovarian Cancer (FINOVA) study
Seija Grenman et al.
EUROPEAN JOURNAL OF CANCER (2006)
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer:: A gynecologic cancer intergroup trial of the AGO-OVAR and GINECO
Jacobus Pfisterer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Diagnosis and management of epithelial ovarian cancer
Snehal Bhoola et al.
OBSTETRICS AND GYNECOLOGY (2006)
Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
DS Kohane et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2006)
Novel formulations of taxanes: a review. Old wine in a new bottle?
KL Hennenfent et al.
ANNALS OF ONCOLOGY (2006)
Worldwide burden of gynaecological cancer: The size of the problem
R Sankaranarayanan et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2006)
Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles
PS Xu et al.
BIOMACROMOLECULES (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
A du Bois et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intrapentoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group study
JL Walker et al.
GYNECOLOGIC ONCOLOGY (2006)
Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxel
J Grant et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel
EA Ho et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Cancer nanotechnology: Opportunities and challenges
M Ferrari
NATURE REVIEWS CANCER (2005)
The transport barrier in intraperitoneal therapy
MF Flessner
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound
ZG Gao et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer
DM Dinulescu et al.
NATURE MEDICINE (2005)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo
BK Kang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian trials in ovarian cancer (MITO-1) randomized study
S De Placido et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim et al.
CLINICAL CANCER RESEARCH (2004)
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel et al.
NATURE REVIEWS CANCER (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Drug resistance reversal - are we getting closer?
RD Baird et al.
EUROPEAN JOURNAL OF CANCER (2003)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Drug delivery and transport to solid tumors
SH Jang et al.
PHARMACEUTICAL RESEARCH (2003)
Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres
Z Liu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
The dawning era of polymer therapeutics
R Duncan
NATURE REVIEWS DRUG DISCOVERY (2003)
Ovulation and risk of epithelial ovarian cancer
DM Purdie et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability
L Milas et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: A gynecologic oncology group study
RJ Schilder et al.
GYNECOLOGIC ONCOLOGY (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Nanoparticles in cancer therapy and diagnosis
I Brigger et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Pluronic® block copolymers for overcoming drug resistance in cancer
AV Kabanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Recent progress in drug delivery systems for anticancer agents
CK Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2002)
Biodegradable injectable in situ forming drug delivery systems
A Hatefi et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age
DW Cramer et al.
HUMAN REPRODUCTION (2002)
Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e6-OV-TL 16 antibody immunoconjugates
JG Shiah et al.
JOURNAL OF CONTROLLED RELEASE (2001)
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
SC Kim et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Role of formulation vehicles in taxane pharmacology
L van Zuylen et al.
INVESTIGATIONAL NEW DRUGS (2001)
Complications associated with intraperitoneal chemotherapy catheters
S Makhija et al.
GYNECOLOGIC ONCOLOGY (2001)
Block copolymer micelles for drug delivery: design, characterization and biological significance
K Kataoka et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Tumor physiology and drug resistance
IF Tannock
CANCER AND METASTASIS REVIEWS (2001)
Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate
C Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs
R Krishna et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
分享论文
